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INTRAOPERATIVE BLOOD TRANSFUSIONS IN HIGHLY 
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LIVER TRANSPLANTATION} 
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Intraoperative blood requirements were analyzed in 
patients undergoing primary orthotopic liver transplan-
tation and divided into two groups on the basis of panel 
reactive antibody of pretransplant serum measured by 
lymphocytotoxicity testing. One group of highly sensi-
tized patients (n = 25) had PRA values of over 70% and 
the second group of patients (n = 26) had Oo/c PRA values 
and were considered nonsensitized. During the trans-
plant procedure, the 70% PRA group received consid-
erably greater quantities of blood products than the 0% 
PRA group-namely, red blood cells: 21.1±3.7 vs. 9.8± 
0.8 units (P = 0.002), and platelets: 17.7:t3.2 vs. 7.5± 
1.5 units (P = 0.003). Similar differences were observed 
for fresh frozen plasma and cryoprecipitate. Despite the 
larger infusion of platelets, the blood platelet counts in 
the 70% PRA group were lower postoperatively than 
preoperatively. Twenty patients in the 70% PRA group 
received platelet transfusions, and their mean platelet 
count dropped from 95,050±11,537 preoperatively to 
67,750±8,228 postoperatively (P = 0.028). In contrast, 
nearly identical preoperative (84,058± 17,297) and 
postoperative (85,64 7±12,445) platelet counts were ob-
served in the 17 0% PRA patients who were transfused 
intraoperatively with platelets. Prothrombin time, ac-
tivated partial thromboplastin time, and fibrinogen lev-
els showed no significant differences between both 
groups. These data demonstrate that lymphocytotoxic 
antibody screening of liver transplant candidates is use-
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ful in identifying patients with increased risk of bleed-
ing problems and who will require large quantities of 
blood during the transplant operation. 
During liver transplantation, major blood loss is of consid-
erable concern and many patients require intraoperative trans-
fusions of rather large quantities of blood components (1-3). 
In a previous series of 87 liver transplant procedures, the 
median red blood cell use was 24 units with a mean of 43 units 
(3). Portal hypertension (4,5) and deficient coagulation profiles 
(4, 6-10) are major causes of intraoperative bleeding, with an 
increased morbidity and mortality in liver transplant patients 
(2,3). 
Although the introduction of a venovenous bypass during the 
an hepatic phase of the operation (11), the guidance of intra-
operative blood replacement by thrombelastography (7), and 
the use of epsilon ·aminocaproic acid (12. 13) have contributed 
to continued reduction in intraoperative blood use, many pa-
tients still experience severe blood loss problems that are not 
readily corrected by blood transfusions. 
We have investigated the role of HLA alloimmunization in 
intraoperative blood transfusion requirements during liver 
transplantation. This alloimmunization can result from pre-
vious exposure to HLA antigens through transfusion, trans-
plantation, and pregnancy and is usually detected by serum 
screening for lymphocytotoxic antibodies. HLA·specific anti-
bodies can mediate hyperacute rejection, and a positive cross· 
match between patient serum and donor cells represents a 
contraindication for successful kidney or heart transplantation 
(14-18). However. liver transplant outcome appears generally 
unaffected by a positive donor-specific crossmatch (19, 20). 
During combined liver-kidney transplantation in patients with 
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preformed donor-specific antibodies, we have observed that 
liver allograft protects the subsequent kidney allograft from 
humoral rejection (21, 22). Thus, it appears that the liver is 
relatively resistant to the potentially deleterious effects of 
donor-specific HLA antibodies. 
On the other hand, HLA alloimmunization plays a significant 
role in blood transfusions, especially those involving platelets. 
It is well known that platelets express class I HLA antigens, 
and specific alloimmunization to these antigens is a ma.jor cause 
of refractoriness of thrombocytopenic patients to platelet trans-
fusions. Alloimmunization-induced platelet refractoriness is 
generally observed in patients with lymphoproliferative disease 
or aplastic anemia who receive long-term transfusion support. 
Such refractory patients will not respond to platelet transfu-
sions from random ABO-matched donors but require HLA-
compatible platelets for effective hemostasis (23-25). 
In this paper we present evidence that HLA alloimmuniza-
tion is associated with increased blood transfusion require-
ments during liver transplantation. This effect is particularly 
apparent for platelet transfusions, which appear to be less 
effective in alloimmunized liver transplant recipients. Our find-
ings indicate that pretransplant lymphocytotoxic antibody 
screening of liver transplant candidates is useful in estimating 
blood transfusion requirements during the transplant proce-
dure. 
MATERIALS AND METHODS 
Two groups of adult patients were selected from our liver transplant 
file on the basis of panel-reactive antibody of pretransplant serum as 
determined by lymphocytotoxicity testing with a panel of 45-60 HLA-
typed donors as previously described (20, 22) One group of 25 highly 
alloimmunized patients showed serum reactivity of greater than 70% 
of the cell panel (the 70% PRA group). The second group of 26 patients 
had PRA values of 0% and were not considered alloimmunized (the 0% 
PRA group). All serum samples were obtained within one month 
pretransplant; 20/26 0% PRA and 18/25 70% PRA patients provided 
serum samples the day before the transplant operation. Although 
previous reports have indicated no correlation between history of prior 
operation and blood loss during liver transplantation (2), we excluded 
patients who had undergone a major operation immediately prior to 
transplantation. Thus. except for PRA, both groups of patients were 
selected randomly. All cases were first transplants performed from 1985 
to 1987. There were no significant differences between the two groups 
of patients with regard to age, body weight, or primary liver disease 
distribution (Table 1). The number of female patients was slightly 
higher in the alloimmunized group but the difference was statistically 
insignificant (P > 0.05). 
Orthotopic transplantation of the liver was performed as already 
described (27) utilizing a venovenous bypass (J 1). The venous bypass 
without systemic heparin anticoagulation restores normal hemody-
namic physiology during the critical anhepatic phase, lowers the intra-
operative blood loss, and increases transplant success (28). in the 70% 
PRA group, only two patients and none of the 0% PRA patients 
underwent splenectomy during transplantation. 
Intraoperative blood repTacement therapy was guided by thrombe· 
lastographic monitoring as previously described (7, 29). 
In each patient group, the intraoperative infusion of red blood cells, 
platelets (PL T),* fresh frozen plasma (FFP), and cryoprecipitate 
I,CRYO) was retrospectively analyzed. In most cases, 1 unit (250 ml) 
of platelets was given together with 1 unit (200 ml) of fresh frozen 
plasma and 250 ml of crystalloids. 
Statistical analysis was done with Student's t test and the Mann-
Whitney U test. Data are shown as mean values ± SE. 
• Abbreviations: CRYO, cryoprecipitate; FFP, fresh frozen plasma; 
PL T, platelets. 
TABLE 1. Distribution of age, weight, sex, and original disease in the 
0<:0 PRA and 70% PRA groups 
Patient criteria 
0'< PRA 70"< PRA 
group group 
Age (years) 44.1±1.7 44.3±2.2 
Weight (kg) 6i.5±3.2 631±3.3 
Female 12 19 
Male 14 6 
Primary biliary cirrhosis 6 6 
Chronic active hepatitis 7 9 
Laennec's disease 6 3 
Fulminant hepatitis 2 1 
Antitrypsin deficiency 3 
Others 4 3 
RESULTS 
Serum antibody analysis was performed on 932 liver trans· 
plants, and 227 patients (24%) had evidence of alloimmuniza-
tion EmoA~1M%F prior to operation, 67 patients (7%) were 
highly sensitized EmoA~TM%FK Highly sensitized patients (70% 
PRA group) required considerably larger quantities of blood 
products intraoperatively than patients with no indication of 
alloimmunization (0% PRA group). Patients in the 70% PRA 
group received 21.1±3.7 units of RBC and 17.7±3.2 units of 
PLT, significantly more than 9.8±0.8 units of RBe and 7.5± 
1.5 units of PL T in the 0% PRA group (Fig. 1) (RBe: P == 
0.002, PLT: P = 0.003). Similarly, significantly larger quantities 
of fresh frozen plasma and cryoprecipitate were given intra-
operatively to the highly alloimmunized group of liver trans-
plant recipients (Fig. 2). 
The preoperative hematocrit values were below the normal 
range of 35-46 in both groups (Tables 2 and 3). Hematocrit 
values were significantly lower in the 70% PRA group (24.6± 
0.7) than in the Oc.c PRA group (28.8±1.0) (P = 0.01). However, 
there was no correlation between decreased preoperative hem-
atocrit values and the intraoperative requirement for infusions 
of blood products in both groups of patients (data not shown). 
The preoperative platelet counts had similar profiles in both 
groups, with 124,038±18,495 in the 0% PRA group and 
106,826±13,714 in the 70% PRA group, (P = 0.52). Intraoper-
ative substitution with platelets can be expected to depend in 
part on the preoperative platelet count, since patients with 
intraoperative bleeding for t~chnical reasons were excluded 
from this study. The lower the basic platelet count before 
operation, the higher the quantity of platelets that should be 
required for transfusion. As shown in Figure 3 (top), this 
expected correlation was observed in the 0% PRA group (P = 
0.0024). In contrast, platelet transfusion requirements showed 
no significant correlation with pretransplant platelet counts in 
the 70% PRA group (P = 0.098) (Fig. 3, bottom). This group 
of highly sensitized patients experienced more bleeding prob-
lems that were not readily corrected by platelet transfusions. 
These bleeding problems were also evident from the increased 
RBe transfusion requirements, which strongly correlated with 
an increase in PL T transfusions in the 70% PRA group (Fig. 
4, bottom) (P < 0,001). In contrast, no correlation was found 
between RBC and PL T transfusion requirements in the 0% 
PRA group (Fig. 4, top) (P = 0.16). 
Despite the larger platelet substitution in the group of highly 
sensitized patients, as shown in Figure I, their postoperative 
platelet counts were significantly reduced as compared with 
preoperative values (Table 3). At the same time, the 0% PRA 
unit 
pl~ 
ser 
tb. 
un' 
ar. 
af. 
de 
5 
he 
± 
's 
\-
d 
t 
"1 
i 
1 
\\ £BER E I' AL_ 799 
50 
40 
30 
unltl 
20 
10 
o 
o 
o 
o 
o 
o 
P.O.OO2 
0 
0 
-
00 
0 
0 
00 
0 
0 
0 
0 
0 
000 
000 
7O'Y. PAA 
ABC 
0 
0 
00 
0 
00 
00 
-000 aoao 
000 
00 
00 
00 
O%PAA 
ABC 
o 
o 
o 
o 
0 0 
P=I_OO3 
0 
ooaoo 
0 
0 
CXlCOOO 
0 
7O'Y.PAA 
PlAT. 
0 
0 
0 
0 
0 
-0 
aoao 
o 
O"JI.PRA 
PlAT, 
Intraoperative tranafvllon 
FIGURE 1. Intraoperative transfusion of red blood cells (RBe) and 
platelet (PLT) in 25 highly sensitized (70% PRA group) and 26 non-
sensitized (0% PRA group) patients. Mean values are depicted with 
thick bars. 
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FIGURE 2. Intraoperative transfusion of fresh frozen plasma (FFP) 
and cryoprecipitate (CRYO) in 25 highly sensitized (70% PRA group) 
and 26 nonsensitized (0% PRA group) patients. Mean values are 
depicted by thick bars. 
TABLE 2. Pre- and posttransplant coagulation profiles in the 0% 
PRA group 
0"0 PRA group 
Hematocrit (o/c) 
Platelet count (xl0'/mmJ) 
Fibrinogen (mg/dl) 
PT (sec) 
APTT (sec) 
Pretransplant Posttransplant Sigmficance (pai,.d t test) 
27.8±1.0 31.5±1.l P=f),034 
124.0±18.4 114.0±14.6 ]'1;5 
190.0±23,9 162,6±19.1 :\5 
14,2±0.5 14,7±0.4 :\5 
41.7±1.8 40,1±1.4 :\5 
TABLE 3. Pre- and posttransplant coagulation profiles in the 70% 
PRA group 
Significance 
iO% PRA group Pretransplant Posttransplant (paired t test) 
Hematocrit (o/c) 24.6±O.7 28.6±O.8 P=O,OOI 
Platelet count (XIO'/mm3 ) 106.8±13.7 82.0±13.7 P=O.OO6 
Fibrinogen (mg/dl) 
PT (sec) 
APTT (sec) 
Platellll 
transfusion 
O"JI.PAA 
group 
(units) 
Platelet 
transfusion 
7O"IoPAA 
group 
(units) 
0 
o 
• 
• 
• 
• 
50 
50 
169.5±16.8 150±11.2 NS 
14.7±0.5 15.5±O.3 NS 
42.6±1.9 44.8±1.6 NS 
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FIGURE 3. Correlation between preoperative blood platelet counts 
and intraoperative platelet transfusions in the l~ PRA group (top) 
and 70% PRA group (bottom). 
group had similar pre- and postoperative platelet counts (Table 
2). Since not all patients of each group were treated with 
platelet transfusions-and thus the overall decreased postop-
erative platelet counts in the 70% PRA group might be due to 
some few patients with no platelet infusions but with deterio-
rated coagulation profile as a result of operation-we compared 
only patients who received intraoperative platelet transfusions 
during the transplant operation. 
In the 70% PRA group, 20 of 25 were intraoperatively given 
platelet infusions. The platelet count showed a significant drop 
from 95,050±11,537 preoperatively to 67,750±8,223 postoper-
atively (P = 0.028). In contrast, 17 of 26 nonsensitized patients 
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FIGURE 5. Differential in blood platelet counts before and after 
operation in transfused patients in the 70% (0) and 0% PRA group 
(0). Mean values are depicted with thick bars. 
received platelets during the transplant operation. Their pre-
(84.058± 17 ,297) and postoperative (85.64 7± 12.445) platelet 
counts were almost identical. Figure 5 shows the differential in 
pre- and postoperative platelet count. The 70% PRA group had 
an average platelet drop of 27 ,300± 11.591. whereas platelet 
counts in the 0<::; PRA group slightly increased by 1588±7756 
(P = 0.018. 
Prothrombin time (normal range 10.8-13.0 sec) and activated 
partial thromboplastin time (normal range 26-34 sec) showed 
similar prolongation in both groups before and after operation 
(Tables 2 and 3). Fibrinogen levels varied widely in both groups. 
but without any statistical significance. The postoperative hem-
atocrit values were about an average of 3-4 % higher than the 
corresponding preoperative values (0% PRA group: P = 0.034, 
70"C PRA group P = 0.001). and borderline statistically signif-
icant differences were observed between the postoperative hem-
atocrit in the 0% and 70% PRA groups (P = 0.053). 
DISCUSSION 
In this study we present evidence that lymphocytotoxic an-
tibody activity in liver transplant recipients is associated with 
intraoperative blood transfusion requirements. Highly sensi-
tized patients with PRA values of greater than 70% received 
during transplant operation much larger quantities of red blood 
cells. platelets. cryoprecipitate. and fresh frozen plasma than 
nonsensitized patients with 0% PRA. This analysis was done 
on patients receiving a first transplant and selected solely on 
the basis of their PRA. Both groups had similar distributions 
of liver diseases, and none of these patients had a previous 
surgical history or intraoperative complications that could have 
been responsible for greater bleeding problems during the trans-
plant procedure. ' 
Lymphocytotoxic antibodies are generally specific for HLA 
antigens. In par1icular, antibodies specific for class I HLA 
antigens controlled by the HLA-A and HLA-B loci are impor-
tant in platelet transfusions (23-25). HLA alloimmunization is 
a major cause of platelet refractoriness of thrombocytopenic 
patients requiring transfusions (23). Such refractory patients 
respond poorly to random ABO-compatible platelets even when 
given in larger quantities. Our data suggest that platelet trans-
fusions are also less effective in correcting the bleeding prob-
lems of highly sensitized patients undergoing liver transplan-
tation. This may even be more apparent from our finding that, 
although the group of patients with high PRA values received 
larger quantities of platelets, they ended up having significantly 
lower platelet counts after the transplant procedure. This lower 
platelet count might be due to the "innocent bystander" effect 
whereby the patients own platelets become involved in the 
immune clearance of transfused incompatible platelets (26). 
Thus. in certain alloimmunized patients, random platelet trans-
fusions would not only be ineffective, but also might worsen 
the bleeding problems during the transplant procedure. 
Our data also show a close correlation between the quantities 
of transfused platelets and ery1hrocytes in the 70% PRA group 
but not in the O"C PRA group. This may be because platelet 
transfusions in the 70% PRA group are not hemostatistically 
effective in correcting intraoperative bleeding problems, which 
would lead to increased requirements for red blood cell substi-
tution in the group of sensitized patients. Nevertheless. recent 
studies have indicated a low expression of HLA class I antigens 
on red blood cells (30), and an involvement of red blood cells 
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. the alloimmune response--either direct or indirect-cannot 
: completely ruled out. The lack of correlation between pre-
erative platelet counts and subsequent intraopertive platelet ~;ansfusion in the 70% PRA gr~up further indicates that he-
ostasis was not merely a functIOn of absolute platelet counts 
:ut of platelet activity. In contrast, the platelet substitution in 
the 0% PRA group was, as expected, inversely proportional to 
the preoperative platelet counts. 
The decreased coagulation status in highly alloimmunized 
patients was also documented ~y d!ffere~ces in plasma replace-
ment requirements and substitutIOn with concentrated frac-
tions of coagulation factors. The 70% PRA group needed sig-
nificantly higher substitution with fresh frozen plasma and 
Cryoprecipitates than the 0% PRA group. Further studies are 
necessary to evaluate intraoperative changes in these coagula· 
tion factors in alloimmunized patients as a possible cause of 
bleeding. 
Our preliminary data presented here show that prothrombin 
time, activated thromboplastin time, and fibrinogen levels had 
identical pre- and postoperative values in both groups. Thus, 
on the basis of a considerably larger substitution in the 70% 
PRA group, we conclude from these findings that major blood 
loss in highly alloimmunized liver transplant patients is caused 
by direct or indirect interference of preformed alloreactive 
antibodies that cause refractoriness to platelet transfusions 
from random donors. The administration of histocompatible 
platelets in these patients might lead to a more effective he-
mostasis and thus lower the quantities of other blood compo-
nents required for substitution. Preoperative screening of pa-
tient sera for panel-reactive antibodies, indicating the degree 
of alloimmunization, would identify liver transplant candidates 
at increased risk of bleeding problems that would require larger 
quantities of blood during transplantation. Highly sensitized 
patients might also benefit from HLA-matched rather than 
random platelet transfusions. 
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